Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals,...
FDA Recall #D-0437-2024 — Class II — March 21, 2024
Product Description
Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India, NDC 6818-0659-06
Reason for Recall
Subpotent Drug
Recalling Firm
Lupin Pharmaceuticals Inc. — Baltimore, MD
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
26,352 bottles
Distribution
Nationwide within the United States
Code Information
Lot #: A201064, Exp. Date March 2024
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated